Suppr超能文献

图像引导栓塞治疗面部动静脉畸形。

Image-Guided Embolotherapy of Arteriovenous Malformations of the Face.

机构信息

Department of Radiology, University Hospital, LMU Munich, Munich, Germany.

Clinic for Radiology, University Hospital Muenster, Muenster, Germany.

出版信息

Cardiovasc Intervent Radiol. 2022 Jul;45(7):992-1000. doi: 10.1007/s00270-022-03169-0. Epub 2022 Jun 2.

Abstract

PURPOSE

To evaluate the safety and outcome of image-guided embolotherapy of extracranial arteriovenous malformations (AVMs) primarily affecting the face.

MATERIALS AND METHODS

A multicenter cohort of 28 patients presenting with AVMs primarily affecting the face was retrospectively investigated. Fifty image-guided embolotherapies were performed, mostly using ethylene-vinyl alcohol copolymer-based embolic agents. Clinical and imaging findings were assessed to evaluate response during follow-up (symptom-free, partial relief of symptoms, no improvement, and progression despite embolization), lesion devascularization (total, 100%; substantial, 76-99%; partial, 51-75%; failure, < 50%; and progression), and complication rates (classified according to the CIRSE guidelines). Sub-analyses regarding clinical outcome (n = 24) were performed comparing patients with (n = 12) or without (n = 12) subsequent surgical resection after embolotherapy.

RESULTS

The median number of embolotherapy sessions was 2.0 (range, 1-4). Clinical outcome after a mean follow-up of 12.4 months (± 13.3; n = 24) revealed a therapy response in 21/24 patients (87.5%). Imaging showed total devascularization in 14/24 patients (58.3%), including the 12 patients with subsequent surgery and 2 additional patients with embolotherapy only. Substantial devascularization (76-99%) was assessed in 7/24 patients (29.2%), and partial devascularization (51-75%) in 3/24 patients (12.5%). Complications occurred during/after 12/50 procedures (24.0%), including 18.0% major complications. Patients with subsequent surgical resections were more often symptom-free at the last follow-up compared to the group having undergone embolotherapy only (p = 0.006).

CONCLUSION

Image-guided embolotherapy is safe and effective for treating extracranial AVMs of the face. Subsequent surgical resections after embolization may substantially improve patients' clinical outcome, emphasizing the need for multimodal therapeutic concepts.

LEVEL OF EVIDENCE

Level 4, Retrospective study.

摘要

目的

评估主要影响面部的颅外动静脉畸形(AVM)的图像引导栓塞治疗的安全性和结果。

材料与方法

回顾性调查了 28 例主要影响面部的 AVM 患者的多中心队列。进行了 50 次图像引导栓塞治疗,主要使用乙烯-乙烯醇共聚物基栓塞剂。评估临床和影像学发现,以在随访期间评估反应(无症状、症状部分缓解、无改善和栓塞后进展)、病变血管化程度(完全,100%;显著,76-99%;部分,51-75%;失败,<50%;进展)和并发症发生率(根据 CIRSE 指南分类)。对栓塞治疗后行(n=12)或不行(n=12)后续手术切除的患者进行了临床结局(n=24)的亚分析比较。

结果

中位数栓塞治疗次数为 2.0(范围,1-4)。平均 12.4 个月(±13.3;n=24)的随访后临床结局显示 24 例患者中有 21 例(87.5%)有治疗反应。影像学显示 14 例患者(58.3%)完全血管化,其中 12 例患者行后续手术,2 例患者仅行栓塞治疗。7 例患者(29.2%)评估为显著血管化(76-99%),3 例患者(12.5%)为部分血管化(51-75%)。50 次手术中有 12 次(24.0%)术中/术后发生并发症,包括 18.0%的严重并发症。最后一次随访时,行后续手术切除的患者无症状的比例高于仅行栓塞治疗的患者(p=0.006)。

结论

图像引导栓塞治疗是治疗面部颅外 AVM 的安全有效的方法。栓塞后行后续手术切除可能会显著改善患者的临床结局,强调需要采用多模态治疗方案。

证据水平

4 级,回顾性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b23/9226106/b6d80b0dd518/270_2022_3169_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验